Clinical Trials
17 trialsNCT01167530 2026-04-06
RAD001
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Completed
NCT02407509 2026-01-29
RAF/MEK
Royal Marsden NHS Foundation Trust
Phase 1 Completed
NCT00655655 2024-08-21
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Phase 1 Completed
NCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
NCT02049047 2022-09-10
ONC-2010-001
Istituto Clinico Humanitas
Phase 2 Completed
NCT01061788 2019-08-28
RAP
Duke University
Phase 1 Completed
NCT01470209 2018-03-19
A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
Emory University
Phase 1 Completed
NCT00807755 2018-01-09
Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors
University of California, Davis
Phase 1 Terminated
NCT00374140 2017-10-19
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
University of Pittsburgh
Phase 2 Completed
NCT00401778 2016-12-21
Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Emory University
Phase 1 Completed
NCT00933777 2016-05-25
SORAVE
University of Cologne
Phase 1 Completed
NCT00096486 2016-01-21
Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT01024946 2015-05-12
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01063478 2014-01-17
RAD001
University of Chicago
Phase 1 Terminated
NCT00406276 2013-08-23
Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer
Emory University
Phase 1/2 Terminated
NCT01079481 2013-05-30
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
Samsung Medical Center
Phase 1 Completed
NCT00892801 2012-03-12
Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Phase 1 Terminated